NCT07099924 Rectus Sheath Catheters Following Midline Laparotomy
| NCT ID | NCT07099924 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Asklepios Kliniken Hamburg GmbH |
| Condition | Acute Abdomen |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-10-06 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-10-06 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Rectus sheath catheters (RSC) are used for postoperative analgesia following midline laparotomies. Local anesthetics are applied to the posterior rectus sheath via the RSC. The target structures are the anterior cutaneous branches of the spinal nerves Th7-Th12. RSC can be used in particular if thoracic epidurals are contraindicated (compromised coagulation), technically unfeasible or refused by the patient. The study investigates placebo-controlled weather RSC have a significant additional analgesic effect in a multimodal analgesic concept. Primary outcome parameters are the maximum pain score, the Quality-of-Recovery-15-Score (QoR-15GE) and the opioid consumption (morphine equivalents) in the first 72h postoperatively.
Eligibility Criteria
Inclusion Criteria: * Median laparotomy * Age over 18 years * Informed consent has been obtained Exclusion Criteria: * Local signs of inflammation * known allergy to local anesthetics used * chronic pain syndrome * drug addiction * post-operative ventilation that cannot be completed on the day of surgery * lack of consent or cooperation * pregnancy * participation in another medical study * sepsis
Contact & Investigator
Ronald Seidel, Dr.med.
PRINCIPAL INVESTIGATOR
Asklepios Klinikum Uckermark
Frequently Asked Questions
Who can join the NCT07099924 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Abdomen. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07099924 currently recruiting?
Yes, NCT07099924 is actively recruiting participants. Contact the research team at ro.seidel@asklepios.com for enrollment information.
Where is the NCT07099924 trial being conducted?
This trial is being conducted at Schwedt, Germany.
Who is sponsoring the NCT07099924 clinical trial?
NCT07099924 is sponsored by Asklepios Kliniken Hamburg GmbH. The principal investigator is Ronald Seidel, Dr.med. at Asklepios Klinikum Uckermark. The trial plans to enroll 40 participants.